Back to Search
ABBAS YOUNES, M.D.
M.D.
Pediatric Otolaryngology Physician
NPI: 1417131434Individual
Specialties, Licenses & Credentials
Pediatric Otolaryngology PhysicianPrimary
Otolaryngology — Pediatric Otolaryngology
Code: 207YP0228X
41490(KY)280195(NY)
Research & Publications (20)
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
PMID 19636010·J Clin Oncol·2009
3-trial
p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis.
PMID 19342895·Cell Cycle·2009
7-preclinical
Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma.
PMID 19465429·Ann Oncol·2009
8-other
Cholinergic receptor signaling modulates spontaneous firing of sinoatrial nodal cells via integrated effects on PKA-dependent Ca(2+) cycling and I(KACh).
PMID 19542482·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Variable-density flow in heterogeneous porous media--laboratory experiments and numerical simulations.
PMID 19674812·J Contam Hydrol·2009
8-other
Heterogeneous pathways of maternal-fetal transmission of human viruses (review).
PMID 19350418·Pathol Oncol Res·2009
6-review
Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
PMID 18509186·J Clin Oncol·2008
6-review
Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
PMID 18343280·Exp Hematol·2008
8-other
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
PMID 18567989·Clin Adv Hematol Oncol·2008
6-review
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
PMID 18764869·Br J Haematol·2008
3-trial
Current role of gemcitabine in the treatment of Hodgkin lymphoma.
PMID 18452104·Leuk Lymphoma·2008
6-review
Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells.
PMID 18356168·J Biol Chem·2008
7-preclinical
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.
PMID 18497318·Blood·2008
8-other
Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answers.
PMID 18469512·Autophagy·2008
6-review
Minimal chemical modification of reductive end of dextran to produce an amphiphilic polysaccharide able to incorporate onto lipid nanocapsules.
PMID 18570391·Bioconjug Chem·2008
8-other
Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma.
PMID 18542117·Nat Clin Pract Oncol·2008
8-other
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.
PMID 18541724·Blood·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 37 RESEARCH WAY
EAST SETAUKET, NY 11733 - Phone
- (631) 444-4545
Quick Facts
- NPI
- 1417131434
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile